Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could your diet influence chemo success? new study investigates

NCT ID NCT06483997

First seen Oct 31, 2025 · Last updated Jun 22, 2026 · Updated 27 times

Summary

This study follows 100 women with breast or gynecologic cancers to see if their diet before chemotherapy is linked to levels of a protein called hepcidin, and whether hepcidin levels affect how much chemo they can receive. The goal is to understand if eating certain foods might help patients tolerate chemotherapy better. No new treatments are being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • George Washington University Cancer Center

    Washington D.C., District of Columbia, 20052, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors understand how diet and hepcidin levels influence chemotherapy effectiveness and side effects, potentially leading to dietary recommendations for cancer patients.

What could go wrong

This is an observational study, not a treatment trial. It only looks for associations, so it cannot prove cause and effect. Results may not lead to any changes in care.

Conditions

The condition(s) this trial relates to.

anemia endometrial cancer endometrium neoplasm fallopian tube cancer fallopian tube neoplasm female breast carcinoma female reproductive organ cancer Inflammation invasive breast carcinoma ovarian cancer ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.